<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00899756</url>
  </required_header>
  <id_info>
    <org_study_id>JS0538</org_study_id>
    <secondary_id>CDR0000491609</secondary_id>
    <secondary_id>NA_00045719</secondary_id>
    <nct_id>NCT00899756</nct_id>
  </id_info>
  <brief_title>Epidermal Growth Factor Receptor Mutations in the Blood of Patients With Advanced Non-Small Cell Lung Cancer</brief_title>
  <official_title>Study of Mutations of Epidermal Growth Factor Receptor in the Blood of Patients With Advanced Non Small Cell Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Collecting and storing samples of blood from patients with cancer to study in the
      laboratory may help doctors learn more about changes that may occur in DNA and identify
      biomarkers related to cancer.

      PURPOSE: This laboratory study is looking at epidermal growth factor receptor mutations in
      the blood of patients with advanced non-small cell lung cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  Determine if epidermal growth factor receptor (EGFR) mutation exists in the peripheral
           blood of patients with advanced non-small cell lung cancer (NSCLC).

        -  Estimate the frequency of EGFR mutation in these patients.

        -  Correlate the presence of EGFR mutation in blood with EGFR mutation in primary or
           metastatic NSCLC tumor block.

      OUTLINE: Patients undergo blood collection for analysis of epidermal growth factor receptor
      mutation by DNA sequencing.

      PROJECTED ACCRUAL: A total of 50 patients will be accrued for this study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2006</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Existence of epidermal growth factor receptor (EGFR) mutations in peripheral blood</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of EGFR mutation</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of participants with EGFR mutation in tissue and plasma.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants with EGFR mutation in peripheral blood and in tumor tissue.</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <enrollment type="Actual">50</enrollment>
  <condition>Lung Cancer</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>molecular diagnostic method</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>mutation analysis</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Any adult patient diagnosed with NSCLC with archiaved tissue availble.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Histologically or cytologically confirmed advanced non-small cell lung cancer

          -  Must have available tumor tissue block

        PATIENT CHARACTERISTICS:

          -  Not specified

        PRIOR CONCURRENT THERAPY:

          -  Not specified
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alex Y. Chang, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Johns Hopkins Singapore International Medical Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alex Chang</name>
      <address>
        <city>Singapore</city>
        <zip>308433</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>May 9, 2009</study_first_submitted>
  <study_first_submitted_qc>May 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2009</study_first_posted>
  <last_update_submitted>February 12, 2019</last_update_submitted>
  <last_update_submitted_qc>February 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>recurrent non-small cell lung cancer</keyword>
  <keyword>stage IIIA non-small cell lung cancer</keyword>
  <keyword>stage IIIB non-small cell lung cancer</keyword>
  <keyword>stage IV non-small cell lung cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

